) has been revised to $9.75 / share. This is a decrease of 15.47% from the prior estimate of $11.54 dated November 7, 2025. The price target is an average of many targets provided by analysts. The ...
We are initiating coverage of TuHURA Biosciences, Inc. (NASDAQ:HURA) with a valuation of $9.25 per share. This value is based on our estimates for successful development and commercialization of IFx-2 ...
MOSCOW, Feb 16 (Reuters) - Alexei Navalny, Russia's most prominent opposition leader, died on Friday after collapsing and losing consciousness at the penal colony north of the Arctic Circle where he ...